Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00536159 · ClinicalTrials.gov registry record · NA
Medicaid Enhanced Prenatal/Postnatal Services Using a Nurse-Community Health Worker Team
A NA study, sponsored by Michigan State University.
- Completed
- Registry status
- NA
- Development phase
- 613
- Enrollment target
NCT00536159: Completed NA study, sponsored by Michigan State University.
NCT00536159 is a NA study that has completed, run by Michigan State University. The registered enrollment target is 613 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (56% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00536159, a NA study, has completed, sponsored by Michigan State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 613 participants
- Enrollment target
Study Summary
Our objective was to test whether there were advantages to Nurse-CHW team home visiting designed to combine the strengths of both visitors, with a focus on maternal stress and mental health, when compared with standard of Community Care (CC) that included professional home visitors in a state-sponsored Medicaid program. We conducted the study under usual community conditions in a population of women eligible for state-sponsored Medicaid programs. We predicted that during pregnancy and infancy, women in the Nurse-CHW team intervention would report 1) less perceived stress; 2) fewer depressive symptoms; and 3) increased levels of psychosocial resources (self-esteem, mastery, and social support) than women in CC. Benefits were expected to be most pronounced for women with low psychosocial resources and high stress at enrollment.
Interventions
- OTHER Medicaid Maternal and Infant Support Services
- OTHER Nurse-CHW team
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 613 participants |
| Start Date | 1997-01 |
| Est. Completion | 2000-08 |
| Phase | NA |
What the finished NCT00536159 record still lists
NCT00536159 is an interventional study that assigns participants to a tested intervention. The registered 613 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (56% lower).
The record links to 0 conditions, and to 2 interventions - of which Medicaid Maternal and Infant Support Services is the first listed.
NCT00536159 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00536159 about?
NCT00536159 is a clinical study titled "Medicaid Enhanced Prenatal/Postnatal Services Using a Nurse-Community Health Worker Team". Our objective was to test whether there were advantages to Nurse-CHW team home visiting designed to combine the strengths of both visitors, with a focus on maternal stress and mental health, when compared with standard of Community Care (CC) that included professional home visitors in a state-sponso...
What is the current status of trial NCT00536159?
This trial is currently completed. It is a NA study. The enrollment target is 613 participants. The study started on 1997-01. Estimated completion is 2000-08.
What interventions are being tested in trial NCT00536159?
The interventions under investigation include: Medicaid Maternal and Infant Support Services (OTHER), Nurse-CHW team (OTHER).
Who is sponsoring clinical trial NCT00536159?
This trial is sponsored by Michigan State University, which has 120 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00536159's enrollment target sits among peer trials
613 161st of 2000 higher than 1,840 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01810913 · 613 participants · Phase 2
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
- NCT03821857 · 614 participants · Phase 4
Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease
- NCT05006716 · 614 participants · Phase 1
A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies
- NCT06170788 · 614 participants · Phase 3
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia